Combining SERCA2a activation and Na-K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac output.

Discovery medicine

Volumn 12, Issue 63, 2011, Pages 141-151

  Gheorghiade, Mihai ^a   Ambrosy, Andrew P ^b   Ferrandi, Mara ^b   Ferrari, Patrizia ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 ((2 AMINOETHOXY)IMINO)ANDROSTANE 6,17 DIONE; 3-((2-AMINOETHOXY)IMINO)ANDROSTANE-6,17-DIONE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DRUG DERIVATIVE; ETIOCHOLANOLONE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL; BIOLOGICAL MODEL; DRUG ANTAGONISM; ENZYMOLOGY; FORWARD HEART FAILURE; HEART FAILURE; HUMAN; METABOLISM; REVIEW;

ANIMALS; CARDIAC OUTPUT, LOW; ETIOCHOLANOLONE; HEART FAILURE; HUMANS; MODELS, BIOLOGICAL; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84858597807     PISSN: None     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Review

References (0)